Effects of vitamin D level on survival in patients with hepatocellular carcinoma [0.03%]
维生素D水平对肝细胞癌患者生存率的影响
Ali Bilgen,Haluk Tarik Kani,Esra Akdeniz et al.
Ali Bilgen et al.
Background and aim: Hepatocellular carcinoma (HCC) is a life-threatening condition of the liver, often concurrent with vitamin D deficiency. In this study, we investigated the relationship between HCC patients' vitamin D ...
Soner Onem,Ozan Cengiz,Suleyman Dolu et al.
Soner Onem et al.
Obesity is a crucial health problem that is common today and may lead to systemic organ dysfunctions. In its treatment, bariatric surgeries are applied with increasing frequency and provide patients lose weight. However, it causes some comp...
Regular coffee intake improves liver enzyme levels and liver histology in patients with chronic alcohol consumption, non-alcoholic fatty liver and non-alcoholic steatohepatitis: Report of 259 cases [0.03%]
_regular_coffee_intake_improves_liver_enzyme_levels_and_liver_histology_in_patients_with_chronic_alcohol_consumption_non_alcoholic_fatty_liver_and_non_alcoholic_steatohepatitis_report_of_259_cases_
翻译后的中文标题如下：
定期摄入咖啡可以改善慢性饮酒者、非酒精性脂肪肝和非酒精性 steatohepatitis 患者的肝酶水平和肝脏组织学：259 例报告
Bulent Degertekin,Nurdan Tozun,Aysegul Gizem Soylemez et al.
Bulent Degertekin et al.
Background and aim: This study aims to investigate the effects of chronic coffee consumption (>5 years) and type of coffee in non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver (NAFLD) and patients who have r...
Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice? [0.03%]
代谢相关脂肪性肝病：是时候在临床实践中采用新的术语了吗？
Coskun Ozer Demirtas,Yusuf Yilmaz
Coskun Ozer Demirtas
Surveillance of hepatocellular carcinoma in cirrhotic patients: Current knowledge and future directions [0.03%]
肝硬化患者肝细胞癌监测：现状与未来方向
Coskun Ozer Demirtas,Osman Cavit Ozdogan
Coskun Ozer Demirtas
Patients with cirrhosis are at the highest risk to develop hepatocellular carcinoma (HCC), with a variable annual risk of 1-8%. Currently, biannual abdominal ultrasound (USG) with or without alpha fetoprotein (AFP) is the recommended HCC su...
A Disquiet Find: Anabolic-androgenic steroids and Vanishing Bile Duct Syndrome [0.03%]
令人不安的发现：雄激素类固醇与胆管消失综合征
Chetan Kalal,Adinath Wagh,Atif Patel et al.
Chetan Kalal et al.
A common practice among young athletes and body-builders is the adoption, use, and self-administration of androgenic anabolic steroid commonly referred to as AASs. Prime classification of these anabolic steroids is either testosterone or sy...
The clinical and histological characteristics of patients with biopsy-proven non-alcoholic fatty liver disease in the absence of insulin resistance [0.03%]
无胰岛素抵抗的活检证实的非酒精性脂肪肝患者的临床和组织学特征
Coskun Ozer Demirtas,Aybuke Sapmaz,Burak Ahmet Gurel et al.
Coskun Ozer Demirtas et al.
Background and aim: Non-alcoholic fatty liver disease (NAFLD) is closely associated with insulin resistance (IR). While a minority of patients with NAFLD does not have evidence of IR, no detailed characterization of this ...
The role of PNPLA3 (rs738409) c>g variant on histological progression of non-alcoholic fatty liver disease [0.03%]
PNPLA3（rs738409）C>G变异在非酒精性脂肪肝病组织学进展中的作用
Ramazan Idilman,Senem Ceren Karatayli,Gokhan Kabacam et al.
Ramazan Idilman et al.
Background and aim: The present study aims to investigate the role of genetic variability of the PNPLA3 gene (adiponectin) in predisposition to non-alcoholic fatty liver disease (NAFLD) by comparing NAFLD patients to heal...
The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases [0.03%]
非酒精性脂肪肝病患者天冬氨酸转氨酶正常和升高时无创评分的诊断价值
Eda Kaya,Alev Bakir,Fatih Eren et al.
Eda Kaya et al.
Background and aim: Noninvasive scores are developed for the estimation of advanced fibrosis, including parameters in addition to transaminases in non-alcoholic fatty liver disease (NAFLD). In this study, we aimed to inve...
From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis [0.03%]
从肝硬化到肝细胞癌：对丙型肝炎病毒致癌机制的探究
Jihad Aljabban,Nilay Danis,Merve Gurakar et al.
Jihad Aljabban et al.
Background and aim: Hepatitis C is a leading cause of chronic liver disease and hepatocellular carcinoma (HCC). Understanding the evolution and biology of HCC among HCV patients may lead to novel therapeutic avenues and r...